相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kanako Terakado Kimura et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies
Agnieszka Jankowska et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs
Mingshuo Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate
Stephen M. Stahl
CNS SPECTRUMS (2018)
Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect
Mingshuo Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects
Pawel Zajdel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study
Pei-Yin Pan et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2018)
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Sheng Wang et al.
NATURE (2018)
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yI)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity
Adam Bucki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics
Hainimu Xiamuxi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies
Dragana Bugarski-Kirola et al.
BIOLOGICAL PSYCHIATRY (2017)
Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study
Lakshmi N. Yatham et al.
LANCET PSYCHIATRY (2017)
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
George Haig et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Synthesis and pharmacological evaluation of piperidine (piperazine)-substituted benzoxazole derivatives as multi-target antipsychotics
Ling Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Synthesis and evaluation of amide, sulfonamide and urea - benzisoxazole derivatives as potential atypical antipsychotics
Yin Chen et al.
MEDCHEMCOMM (2015)
Investigational drugs for anxiety in patients with schizophrenia
Ricardo P. Garay et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
What Can Crystal Structures of Aminergic Receptors Tell Us about Designing Subtype-Selective Ligands?
Mayako Michino et al.
PHARMACOLOGICAL REVIEWS (2015)
Efficacy and Safety of the Glycine Transporter-1 Inhibitor Org 25935 for the Prevention of Relapse in Alcohol-Dependent Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Andrea de Bejczy et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)
Effect of Aripiprazole Augmentation for Treatment-Resistant Somatoform Disorder A Case Series
Yasuhide Nagoshi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies
Margherita Brindisi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey
Donnie Eddins et al.
PSYCHOPHARMACOLOGY (2014)
Synthesis and Biological Investigation of Coumarin Piperazine (Piperidine) Derivatives as Potential Multireceptor Atypical Antipsychotics
Yin Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Stefan Leucht et al.
LANCET (2013)
Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents
Kwakye Peprah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Neurocognitive function in long-term treated schizophrenia: A five-year follow-up study
Maria Ekerholm et al.
PSYCHIATRY RESEARCH (2012)
Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
Jason R. Tregellas et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory
Satoshi Ikemoto
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors: Design, Synthesis, and Effects on Behavior
Stefania Butini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
S. Leucht et al.
PSYCHOLOGICAL MEDICINE (2009)
Psychiatric Comorbidities and Schizophrenia
Peter F. Buckley et al.
SCHIZOPHRENIA BULLETIN (2009)
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia - Is it a practice effect?
Terry E. Goldberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia
S Kapur et al.
ANNUAL REVIEW OF MEDICINE (2001)
分享论文
